VRTX
Insider TradingVertex Pharmaceuticals
Health Care / Biotechnology
Recent Insider Transactions
Source: SEC Form 4 filings. Updated daily. Transaction codes: P = Open-Market Purchase, S = Open-Market Sale, F = Tax Withholding, A = Award, M = Option Exercise.
| Date | Reporter | Type | Shares | Price | Total Value |
|---|---|---|---|---|---|
| May 19, 2026 | Bunnage Mark E. EVP, Chief Scientific Officer | SOpen-Market Sale10b5-1 | 33 | $453.45 | $15K |
| May 19, 2026 | Bozic Carmen EVP and CMO | SOpen-Market Sale10b5-1 | 1,354 | $453.45 | $614K |
| May 14, 2026 | Bozic Carmen EVP and CMO | SOpen-Market Sale10b5-1 | 6,988 | $450.00 | $3.1M |
| May 5, 2026 | Thornberry Nancy | AAward | 472 | $0.00 | $0.00 |
| May 5, 2026 | SACHS BRUCE I | AAward | 2,866 | $0.00 | $0.00 |
| May 5, 2026 | Upadhyay Suketu | DD | 796 | - | - |
| May 5, 2026 | Bhatia Sangeeta N. | AAward10b5-1 | 943 | $0.00 | $0.00 |
| May 5, 2026 | MCKENZIE DIANA | AAward | 943 | $0.00 | $0.00 |
| May 5, 2026 | CARNEY LLOYD | AAward | 2,866 | $0.00 | $0.00 |
| May 5, 2026 | Garber Alan M | AAward | 472 | $0.00 | $0.00 |
| May 5, 2026 | Lagarde Michel | AAward | 2,866 | $0.00 | $0.00 |
| May 5, 2026 | Schneider Jennifer | AAward | 472 | $0.00 | $0.00 |
| May 5, 2026 | Liu Joy EVP and Chief Legal Officer | SOpen-Market Sale10b5-1 | 1,104 | $425.02 | $469K |
| Mar 31, 2026 | Bozic Carmen EVP and CMO | SOpen-Market Sale10b5-1 | 2,329 | $450.95 | $1.1M |
| Mar 17, 2026 | Bozic Carmen EVP and CMO | SOpen-Market Sale10b5-1 | 2,329 | $481.79 | $1.1M |
| Mar 13, 2026 | McKechnie Duncan EVP, Chief Commercial Officer | SOpen-Market Sale10b5-1 | 2,633 | $498.42 | $1.3M |
| Mar 6, 2026 | McKechnie Duncan EVP, Chief Commercial Officer | SOpen-Market Sale10b5-1 | 2,437 | $475.30 | $1.2M |
| Mar 4, 2026 | Liu Joy EVP and Chief Legal Officer | SOpen-Market Sale10b5-1 | 892 | $495.96 | $442K |
| Mar 3, 2026 | Bozic Carmen EVP and CMO | SOpen-Market Sale10b5-1 | 2,329 | $480.31 | $1.1M |
| Mar 3, 2026 | Kewalramani Reshma CEO & President | SOpen-Market Sale10b5-1 | 400 | $479.75 | $192K |
| Feb 26, 2026 | McKechnie Duncan EVP, Chief Commercial Officer | FTax Withholding | 873 | $485.11 | $424K |
| Feb 26, 2026 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | FTax Withholding | 1,627 | $485.11 | $789K |
| Feb 26, 2026 | Ambrose Kristen SVP & Chief Accounting Officer | FTax Withholding | 546 | $485.11 | $265K |
| Feb 26, 2026 | Bozic Carmen EVP and CMO | FTax Withholding | 1,453 | $485.11 | $705K |
| Feb 26, 2026 | LEIDEN JEFFREY M Executive Chairman | FTax Withholding | 3,547 | $485.11 | $1.7M |
| Feb 26, 2026 | Bunnage Mark E. EVP, Chief Scientific Officer | FTax Withholding | 582 | $485.11 | $282K |
| Feb 26, 2026 | Kewalramani Reshma CEO & President | FTax Withholding | 4,981 | $485.11 | $2.4M |
| Feb 26, 2026 | Sachdev Amit EVP Chief Patient & Ext Af Off | FTax Withholding | 1,518 | $485.11 | $736K |
| Feb 26, 2026 | Biller Jonathan EVP and Chief Legal Officer | FTax Withholding | 1,144 | $485.11 | $555K |
| Feb 26, 2026 | WAGNER CHARLES F JR EVP, CO & FO | FTax Withholding | 1,744 | $485.11 | $846K |
| Feb 26, 2026 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | FTax Withholding | 1,627 | $485.11 | $789K |
Get VRTX insider alerts in your inbox
The Filing Cabinet tracks SEC Form 4 filings for every S&P 500 company and delivers a free daily digest of the most significant insider trades.